Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Carotid revascularization · Arkansas | Carotid revascularization · Florida | |
|---|---|---|
| Surgeons, 2024 | 13 | 67 |
| Medicare fee-for-service cases | 532 | 3,226 |
| Growth since 2019 (Medicare FFS) | −8.8%/yr | −2.7%/yr |
| Forecast cases (Medicare FFS) | 550 in 2030 | 3,330 in 2030 |
| Forecast growth | +0.4%/yr to 2030 | +0.5%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 1.4 | 1.4 |
| Medicare Advantage share | 49% | 60% |
| Out of hospital | 0% (+0 pts since 2019) | 0% (+0 pts since 2019) |
| Cases per surgeon | 41 | 48 |
| Top 10 surgeons' share | 86% | 29% |
| Surgeons growing | 1 | 5 |
| New since the base year | 1 | 5 |
| Likely to stop billing it | 6 by 2026 | 33 by 2026 |
| Forecast miss, 1 year (procedure) | 6% | 6% |
| Company payments per surgeon | $562 | $2,907 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.